27 identified a Mu opioid receptor, expressed on the B lymphocytes surface, as a biological marker (named Mu-Lympho-Maker) for an objective chronic pain diagnosis of fibromyalgia. The gene discussed is OPRM1; the disease is fibromyalgia.